Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatment
about
Bone Mineral Density in Schizophrenia: An Update of Current Meta-Analysis and Literature Review Under Guideline of PRISMAAntipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks.Chronic Psychosocial Stress Impairs Bone Homeostasis: A Study in the Social Isolation Reared Rat.Atypical antipsychotic drugs inhibit trabecular bone accrual in C57BL/6J mice.A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.Hyperprolactinemia with antipsychotic drugs in children and adolescents.Paliperidone: the evidence of its therapeutic value in schizophrenia.Bone density in chronic schizophrenia with long-term antipsychotic treatment: preliminary studyPhysical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Clinical correlates of vitamin D deficiency in established psychosis.Osteoporosis and fracture risk in people with schizophreniaFactors associated with decreased bone mineral density in postmenopausal women with schizophrenia.Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder.Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications.Risperidone-associated prolactin elevation and markers of bone turnover during acute treatment.Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.Possible mechanisms for the skeletal effects of antipsychotics in children and adolescentsGender differences in antipsychotic prescribing.Antipsychotic-induced hyperprolactinaemia.Adverse skeletal effects of drugs - beyond Glucocorticoids.Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.No association between bone mass and prolactin levels among patients with schizophrenia.High bone turnover but normal bone mineral density in women suffering from schizophrenia.[Bone histomorphometry of lactating and no lactating hyperthyroid rats].Change in sexual dysfunction with aripiprazole: a switching or add-on study.Gender-specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis.
P2860
Q26775158-AFB57352-5B37-4B5F-A141-D0E7E05AA2F4Q30370326-C78B9A56-47F7-484C-8D1D-6C834AE52BE1Q30380187-986D86BD-6E8E-4FED-B590-2D1B2ABF0E02Q33622146-10F54E73-9679-4D3B-8160-26A07647A279Q33755068-D3B80A8D-B1E2-466C-8E0F-D7FF6865404DQ34143459-F564B7E9-05BC-498D-9D56-5F83AA2D6E3BQ34449894-BA664FC3-02B0-43CA-9CE1-BBA3AE7676C3Q34497563-C77F68D8-494A-422B-95DE-639404188FEBQ34623350-9082C0D6-9D16-4D57-AD3D-4DF394942F40Q35965185-75E0929E-0118-4D12-BA38-69A2CD70B472Q36592205-F999A5ED-9066-4DC9-A67B-CD9A425887C3Q36603968-F33DF5AB-9F13-40E2-9FA1-B1A3BB4B240AQ36882931-F60D753A-D909-488A-B768-11AD477064CFQ37064780-36900787-F3A6-4074-84E0-533C4CBC08C9Q37078982-5CDA61BC-8FAD-44A2-ACD9-3A8BE591013CQ37162808-0E78AFD5-207F-44F5-9246-AC540DD3DF46Q37247927-74BF8DE9-E645-48F6-A4B3-DC8CF597CA40Q37806755-FC6C0BCB-2517-43E4-97CA-267BB4DC6F64Q37895702-C67670CE-9D91-4188-ACFA-EC5215F10880Q38231316-799889A7-00FF-4C35-9712-9C881B4FC400Q38778145-7262DB82-0B14-4680-AEB9-A26CF36DD14EQ39684311-03DA1B1F-0CE9-4319-8B6D-D0E311865DA8Q46351516-A493D0E4-08B6-4449-A965-9EAB922C2E9AQ46499356-816BBC85-C362-478E-9651-CCDDBE2F0A47Q46727015-0906DFEC-504A-48AA-A9D9-2EDCDEB6A9BDQ47557751-E1D35AAD-78B4-41ED-83BC-39C7BAAD3E52
P2860
Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatment
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Bone mineral density and its r ...... taking antipsychotic treatment
@en
type
label
Bone mineral density and its r ...... taking antipsychotic treatment
@en
prefLabel
Bone mineral density and its r ...... taking antipsychotic treatment
@en
P2093
P2860
P50
P1476
Bone mineral density and its r ...... taking antipsychotic treatment
@en
P2093
Anna-Maria Meaney
Glen Blake
Ignac Fogelman
Michael J Wheeler
P2860
P304
P356
10.1097/01.JCP.0000162798.87249.4D
P407
P577
2005-06-01T00:00:00Z